{"schema_version":"secwatch.filing_event.v1","accession":"0001156039-25-000056","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2025-04-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.651365+00:00","generated_at":"2026-05-23T09:01:04.784926+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Elevance Health Q1 2025 revenue $48.8B (+15.4% YoY); adj. diluted EPS $11.97; reaffirms FY guidance","bullets":["Operating revenue $48.8B (+15.4% YoY); diluted GAAP EPS $9.61, adjusted diluted EPS $11.97.","Benefit expense ratio 86.4% (+80 bps YoY); operating expense ratio 10.9% (-70 bps).","Health Benefits segment op. revenue $41.4B, op. gain $2.2B; Carelon op. revenue $16.7B, op. gain $1.1B.","Medical membership ~45.8M (+99K from year-end); returned $1.3B capital via buybacks & dividends.","Reaffirmed FY 2025 adjusted diluted EPS guidance $34.15-$34.85; Q2 dividend $1.71/share declared."],"urls":{"canonical":"https://secwatch.observer/filing/0001156039-25-000056","json":"https://secwatch.observer/filing/0001156039-25-000056.json","markdown":"https://secwatch.observer/filing/0001156039-25-000056.md","text":"https://secwatch.observer/filing/0001156039-25-000056.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000056/0001156039-25-000056-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000056/elv-20250422.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T09:01:04.784926+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}